Introduction:

Non-alcoholic liver steatosis is the most frequent disease in the world. It is associated with type 2 diabetes mellitus, representing great economic-social impact.

Objective:

To describe the behavior of hepatic steatosis in a population of patients diagnosed with type 2 diabetes mellitus.

Methods:

An observational, descriptive, cross-sectional study was conducted in 94 diabetic patients treated at Hermanos Ameijeiras Clinical Surgical Hospital, from February 2016 to February 2018.

Results:

Steatosis was mild in 42.6%, moderate (44.7%) and severe in 12.8%, with a mainly indeterminate NAFLD score (72.3%). F0-1 fibrosis was detected in 58.5% of the patients, F2 (29.8%) and significant (F3 and F4) in 11.7%). Association between increased liver echogenicity, diffuse liver pattern and severe degree of steatosis were ostensible by ultrasound with higher degree of fibrosis according to elastography. Significant relationship of elevated levels of HBA1C with significant fibrosis was detected, measured both by NAFLD score and by elastography.

Conclusions:

Hepatic steatosis present in patients with diabetes mellitus was mainly mild to moderate with prevalence of mild fibrosis, the degree of significant fibrosis was associated with increased liver echogenicity, diffuse liver pattern, severe degree of steatosis by ultrasound and high levels of hemoglobin. glycosylated.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )